194 related articles for article (PubMed ID: 31015308)
1. Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.
Sima LE; Yakubov B; Zhang S; Condello S; Grigorescu AA; Nwani NG; Chen L; Schiltz GE; Arvanitis C; Zhang ZY; Matei D
Mol Cancer Ther; 2019 Jun; 18(6):1057-1068. PubMed ID: 31015308
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction.
Yakubov B; Chen L; Belkin AM; Zhang S; Chelladurai B; Zhang ZY; Matei D
PLoS One; 2014; 9(2):e89285. PubMed ID: 24586660
[TBL] [Abstract][Full Text] [Related]
3. Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.
Condello S; Sima L; Ivan C; Cardenas H; Schiltz G; Mishra RK; Matei D
Cancer Res; 2018 Jun; 78(11):2990-3001. PubMed ID: 29510995
[TBL] [Abstract][Full Text] [Related]
4. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.
Wang Z; Collighan RJ; Gross SR; Danen EH; Orend G; Telci D; Griffin M
J Biol Chem; 2010 Dec; 285(51):40212-29. PubMed ID: 20929862
[TBL] [Abstract][Full Text] [Related]
5. Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase.
Khanna M; Chelladurai B; Gavini A; Li L; Shao M; Courtney D; Turchi JJ; Matei D; Meroueh S
Mol Cancer Ther; 2011 Apr; 10(4):626-36. PubMed ID: 21330459
[TBL] [Abstract][Full Text] [Related]
6. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
[TBL] [Abstract][Full Text] [Related]
7. Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.
Yakubov B; Chelladurai B; Schmitt J; Emerson R; Turchi JJ; Matei D
Neoplasia; 2013 Jun; 15(6):609-19. PubMed ID: 23730209
[TBL] [Abstract][Full Text] [Related]
8. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin.
Akimov SS; Krylov D; Fleischman LF; Belkin AM
J Cell Biol; 2000 Feb; 148(4):825-38. PubMed ID: 10684262
[TBL] [Abstract][Full Text] [Related]
9. Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.
Forsprecher J; Wang Z; Nelea V; Kaartinen MT
Amino Acids; 2009 Apr; 36(4):747-53. PubMed ID: 18604470
[TBL] [Abstract][Full Text] [Related]
10. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.
Condello S; Cao L; Matei D
FASEB J; 2013 Aug; 27(8):3100-12. PubMed ID: 23640056
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
Stamnaes J; Cardoso I; Iversen R; Sollid LM
FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
[TBL] [Abstract][Full Text] [Related]
12. The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2.
Tanaka K; Yokosaki Y; Higashikawa F; Saito Y; Eboshida A; Ochi M
Matrix Biol; 2007 Jul; 26(6):409-18. PubMed ID: 17490870
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2 has higher affinity for relaxed than for stretched fibronectin fibers.
Selcuk K; Leitner A; Braun L; Le Blanc F; Pacak P; Pot S; Vogel V
Matrix Biol; 2024 Jan; 125():113-132. PubMed ID: 38135164
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the interaction between transglutaminase 2 and fibronectin.
Cardoso I; Østerlund EC; Stamnaes J; Iversen R; Andersen JT; Jørgensen TJ; Sollid LM
Amino Acids; 2017 Mar; 49(3):489-500. PubMed ID: 27394141
[TBL] [Abstract][Full Text] [Related]
15. Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex.
Wang Z; Telci D; Griffin M
Exp Cell Res; 2011 Feb; 317(3):367-81. PubMed ID: 21036168
[TBL] [Abstract][Full Text] [Related]
16. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.
Herman JF; Mangala LS; Mehta K
Oncogene; 2006 May; 25(21):3049-58. PubMed ID: 16449978
[TBL] [Abstract][Full Text] [Related]
17. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling.
Telci D; Wang Z; Li X; Verderio EA; Humphries MJ; Baccarini M; Basaga H; Griffin M
J Biol Chem; 2008 Jul; 283(30):20937-47. PubMed ID: 18499669
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2).
Valdivia A; Vagadia PP; Guo G; O'Brien E; Matei D; Schiltz GE
J Med Chem; 2023 Jul; 66(14):9445-9465. PubMed ID: 37449845
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.
Chen SH; Lin CY; Lee LT; Chang GD; Lee PP; Hung CC; Kao WT; Tsai PH; Schally AV; Hwang JJ; Lee MT
Anticancer Res; 2010 Oct; 30(10):4177-86. PubMed ID: 21036738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
